RankAlpha logo
Back to Rankings

PHVS

PharvarisD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
PHVS vs peer average
32/100
PHVS vs. peer average (D vs. C)
Grade spread
B 3 · C 3 · D 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

SLS is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $2.4B

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerSLSSELLAS Life Sciences Group
PHVS
Pharvaris
SLS
SELLAS Life Sciences Group
Grade
D
D
Momentum
57
100
Value
41
41
Sentiment
-
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs SLS

PHVS / SLS
Grade Position
Below peers
PHVS vs. peer average (D vs. C)
32/100
Momentum
57
SLS
Value
41
PHVS
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs PHVS
1
SLS
SELLAS Life Sciences Group Inc Common
D
40/100
Even
2
BCRX
BioCryst Pharmaceuticals Inc Common
B
80/100
-2
3
MLYS
Mineralys Therapeutics Inc Common
C
60/100
-1
4
NRIX
Nurix Therapeutics Inc Common
C
60/100
-1
5
IOVA
Iovance Biotherapeutics Inc Common
D
40/100
Even
SLS is the first peer returned for this comparison set.